Tag: our research

Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a new test system.

The NIHR announced yesterday that they have published a framework for restarting research activities that have a been paused as a result of Covid-19.

The Center for Advancing Innovation (CAI) announces winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.

Scientists carried out a large-scale study of 241 infants from around the world.

When her grandson Logan died from a DIPG brain tumour in 2017, Fiona vowed to drive change for everyone affected.

Last week, our first lab tour of 2020 gave some of our supporters a chance to witness our funded research first-hand.

An affordable, point of care blood test to diagnose brain tumours was announced today by The University of Bristol.

The level of funding into the research of brain tumours in the UK has increased overall by a third, according to figures released by the National Cancer Research Institute (NCRI).

On January 31, the UK formally left the European Union (EU). As a result, we have now entered into an 11-month transition period, as the future UK-EU relationship is negotiated.

The phase 3 clinical trial aims to study oral eflornithine as a possible new treatment for patients with recurrent anaplastic astrocytoma.

This new role will establish and lead programmes in neuro-oncology and neuro-immunology, a step forward for our community.

Yesterday an Italian court upheld a ruling that prolonged use of mobile phones caused a man’s brain tumour despite worldwide research finding no link.

Get ready to crumble by baking a difference for everyone affected by brain tumours this March.

Widely reported, the artificial intelligence diagnosis was faster than a pathologist, just…

Co-funded by us, Children with Cancer UK and Action Medical Research, the study from the University of Birmingham is the first of its kind.

New diagnostic techniques are driving real change in treatments for childhood brain tumours, a study reveals.

Our community have come together to share their stories and their wishes for our Winter Appeal, creating a powerful campaign.

Reported in The Times this morning, thousands have benefited over the last ten years due to surgical improvements.

Reported at this week’s The National Cancer Research Institute (NCRI) conference, the innovative test could change the way brain tumours are diagnosed earlier.

Researchers have developed a blood test that could help identify people with a brain tumour, even if they have no clear-cut symptoms.

A study released this morning revealed that too few children are receiving targeted drugs for their cancers

Tocagen, an American gene-therapy company, announced the trial’s failure yesterday.

This morning saw the release of the annual results from the English National Cancer Patient Experience Survey for 2018.

New findings out of the University of Sussex could be paving the way to a new test for glioblastoma (GBM) using only fluids, like blood or cerebrospinal fluid.